An observational study in Sports Physical Therapy, sponsored by Institut Cancerologie de l'Ouest. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-27.
Sponsored by Institut Cancerologie de l'Ouest · Observational
The objective of this study is to evaluate the effects of regular physical practice on fatigue, quality of life and kinesiophobia in patients treated at the ICO in Angers, regardless of the type of cancer and the type of treatment.
The objective of this study is to evaluate the effects of regular physical practice on fatigue, quality of life and kinesiophobia in patients treated at the ICO in Angers, regardless of the type of cancer and the type of treatment.
A 12-week Adapted Physical Activity program (APA) is proposed to patients included in the study with an assessment of fatigue, quality of life, level of physical activity and kinesiophobia (fear of movement) at the beginning of the study.
A second assessment of fatigue and quality of life will be done during the 6-week management.
At the end of the program, a final evaluation of fatigue, quality of life and kinesiophobia will be done.
243 studies on the registry are indexed under Kinesiophobia; 89 are open to participants now.
This study's enrollment of 37 is below the median of 77 across 98 observational studies indexed under Kinesiophobia.
Browse Kinesiophobia studies →Institut Cancerologie de l'Ouest is the lead sponsor of 105 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects participating in the ICO's APA program during the enrolment period regardless of the type of cancer and the type of treatment in progress (chemotherapy, radiotherapy, hormone therapy, immunotherapy) who accept to participate to the study.
Exclusion Criteria:
Adults participating in the APA program at ICO during the first semester of 2020, regardless of cancer type and ongoing treatment (chemotherapy, radiotherapy, hormone therapy, immunotherapy). The APA program duration is : 12 weeks
Quality of Life of Patients Participating in the 12-week Adapted Physical Activity Program.
Describe the evolution of the quality of life of patients being treated for their cancer pathology at the ICO site in Angers, and participating in the 12-week adapted physical activity program at ICO. Quality of life is measured with the FACIT-F Fatigue and Quality of Life Questionnaire. The questionnaire is structured into five sections, each containing between 6 and 13 items. In total, it includes 40 items, each scored from 0 to 4: 0 - Not at all 1. \- A little 2. \- Moderately 3. \- Quite a bit 4. \- Very much By adding up the answers, the score range obtained is: 0 to 160. The higher the score, the less tired the patient is.
Time frame: 12 weeks
Describe Attendance at the APA Program.
The number of sessions is planned by the APA coach at the beginning of the APA program. The number of performed sessions is measured.
Time frame: 12 weeks
Measure the Evolution of Kinesiophobia (Fear of Movement).
Kinesiophobia is measured with the TAMPA Scale for Kinesiophobia (TSK-CF). This scale assesses the kinesiophobia index presented by the patient at the time of the assessment. The higher the score, the greater the level of kinesiophobia. Total score range: 17 to 68. Higher scores indicate greater fear of movement. A score ≥ 40 is considered significant kinesiophobia.
Time frame: 12 weeks
Measure Physical Activity at the Initiation of the APA Program.
The level of physical activity (PA) is assessed using the GPAQ questionnaire. The questionnaire consists of 16 items. Physical activity is expressed in MET-minutes per week (Metabolic Equivalent of Task), calculated from reported activity. Based on the score, three profiles are defined: High * ≥3 days vigorous activity (≥1500 MET-min/week) OR * ≥7 days walking/moderate/vigorous PA (≥3000 MET-min/week) Moderate * ≥20 min vigorous PA / day, ≥3 days/week OR * ≥30 min moderate PA/walking / day, ≥5 days/week OR * ≥5 days mixed activity (≥600 MET-min/week) Low * Does not meet above criteria
Time frame: Week 0
Study start date first signed consent: 14 SEP 2020 Date of first patient inclusion: 14 SEP 2020 End of trial date (last visit of last patient): 14 MAR 2021
| Milestone | Adapted Physical Activity (APA) |
|---|---|
| Started | 37 |
| Completed | 33 |
| Not completed | 4 |
| Withdrew: Withdrawal by subject | 3 |
| Withdrew: Performance status alteration not related to study procedure | 1 |
Describe the evolution of the quality of life of patients being treated for their cancer pathology at the ICO site in Angers, and participating in the 12-week adapted physical activity program at ICO. Quality of life is measured with the FACIT-F Fatigue and Quality of Life Questionnaire. The questionnaire is structured into five sections, each containing between 6 and 13 items. In total, it includes 40 items, each scored from 0 to 4: 0 - Not at all 1. \- A little 2. \- Moderately 3. \- Quite a bit 4. \- Very much By adding up the answers, the score range obtained is: 0 to 160. The higher the score, the less tired the patient is.
| score on a scale | Adapted Physical Activity (APA) |
|---|---|
| Quality of Life of Patients Participating in the 12-week Adapted Physical Activity Program. | 117.6 ± 23.5 |
The number of sessions is planned by the APA coach at the beginning of the APA program. The number of performed sessions is measured.
| Number of APA sessions | Adapted Physical Activity (APA) |
|---|---|
| Describe Attendance at the APA Program. | 14.2 ± 6.3 |
Kinesiophobia is measured with the TAMPA Scale for Kinesiophobia (TSK-CF). This scale assesses the kinesiophobia index presented by the patient at the time of the assessment. The higher the score, the greater the level of kinesiophobia. Total score range: 17 to 68. Higher scores indicate greater fear of movement. A score ≥ 40 is considered significant kinesiophobia.
| score on a scale | Adapted Physical Activity (APA) |
|---|---|
| Measure the Evolution of Kinesiophobia (Fear of Movement). | 34.45 ± 6.02 |
The level of physical activity (PA) is assessed using the GPAQ questionnaire. The questionnaire consists of 16 items. Physical activity is expressed in MET-minutes per week (Metabolic Equivalent of Task), calculated from reported activity. Based on the score, three profiles are defined: High * ≥3 days vigorous activity (≥1500 MET-min/week) OR * ≥7 days walking/moderate/vigorous PA (≥3000 MET-min/week) Moderate * ≥20 min vigorous PA / day, ≥3 days/week OR * ≥30 min moderate PA/walking / day, ≥5 days/week OR * ≥5 days mixed activity (≥600 MET-min/week) Low * Does not meet above criteria
| Participants | Adapted Physical Activity (APA) |
|---|---|
| High activity level | 1 |
| Moderate activity level | 19 |
| Low activity level | 17 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Adapted Physical Activity (APA) | — | — | — |
Cancer patients
| Age, Continuous(Years) | Adapted Physical Activity (APA) |
|---|---|
| Mean | 52.7 ± 11.5 |
| Sex: Female, Male(Participants) | Adapted Physical Activity (APA) |
|---|---|
| Female | 30 |
| Male | 7 |
| Race and Ethnicity Not Collected(Participants) | Adapted Physical Activity (APA) |
|---|
| Region of Enrollment(Participants) | Adapted Physical Activity (APA) |
|---|---|
| France | 37 |
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Cancerologie de l'Ouest